| The safety of green tea and green tea extract consumption in adults - Results of a systematic review |
34 |
| A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans |
27 |
| Distribution of fluoride contamination in drinking water resources and health risk assessment using geographic information system, northwest Iran |
27 |
| Toxicity of silver ions, metallic silver, and silver nanoparticle materials after in vivo dermal and mucosal surface exposure: A review |
26 |
| Physico-chemical properties of manufactured nanomaterials - Characterisation and relevant methods. An outlook based on the OECD Testing Programme |
24 |
| A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes |
22 |
| In silico toxicology protocols |
20 |
| Assessment of novel tobacco heating product THP1.0. Part 3: Comprehensive chemical characterisation of harmful and potentially harmful aerosol emissions |
17 |
| A review on silver nanoparticles-induced ecotoxicity and the underlying toxicity mechanisms |
16 |
| Human health risk assessment: Study of a population exposed to fluoride through groundwater of Agra city, India |
15 |
| A reappraisal on metformin |
15 |
| Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting |
14 |
| Characterizing risk assessments for the development of occupational exposure limits for engineered nanomaterials |
13 |
| Pesticide exposure and risk of Parkinson's disease: Dose-response meta-analysis of observational studies |
13 |
| Non-clinical toxicity of beta-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice |
13 |
| Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of action |
13 |
| Bridging communities in the field of nanomedicine |
12 |
| Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria |
12 |
| An evaluation of electronic cigarette formulations and aerosols for harmful and potentially harmful constituents (HPHCs) typically derived from combustion |
11 |
| Developing OECD test guidelines for regulatory testing of nanomaterials to ensure mutual acceptance of test data |
11 |
| Assessment of tobacco heating product THP1.0. Part 2: Product design, operation and thermophysical characterisation |
11 |
| Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults |
11 |
| Chemical analysis and in vitro toxicological evaluation of aerosol from a novel tobacco vapor product: A comparison with cigarette smoke |
11 |
| Oxidative stress responses in human bronchial epithelial cells exposed to cigarette smoke and vapor from tobacco- and nicotine-containing products |
10 |
| Distinguishing between endocrine disruption and non-specific effects on endocrine systems |
10 |
| Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model |
9 |
| Assessment of novel tobacco heating product THP1.0. Part 7: Comparative in vitro toxicological evaluation |
9 |
| Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromides |
9 |
| Status of acute systemic toxicity testing requirements and data uses by US regulatory agencies |
9 |
| Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in Sprague Dawley rats |
8 |
| A comparison of in vitro cytotoxicity assays in medical device regulatory studies |
8 |
| Reflections on the progress towards non-animal methods for acute toxicity testing of chemicals |
8 |
| Genetic toxicology in silico protocol |
8 |
| An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates |
8 |
| Taurine treatment decreases inflammation and oxidative stress in lungs of adult mice exposed to cigarette smoke |
8 |
| Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine |
8 |
| Drug adulteration of food supplements: A threat to public health in the European Union? |
8 |
| Molecular fingerprint-derived similarity measures for toxicological read-across: Recommendations for optimal use |
8 |
| Fragrance allergens in household detergents |
8 |
| A monitoring survey and dietary risk assessment for pesticide residues on peaches in China |
8 |
| International regulatory requirements for skin sensitization testing |
8 |
| Toxicological evaluation of 6 '-sialyllactose (6 '-SL) sodium salt |
8 |
| Perfluorohexanoic acid toxicity, part II: Application of human health toxicity value for risk characterization |
8 |
| Perfluorohexanoic acid toxicity, part I: Development of a chronic human health toxicity value for use in risk assessment |
8 |
| Micronutrient and heavy metal concentrations in basil plant cultivated on irradiated and non-irradiated sewage sludge-treated soil and evaluation of human health risk |
7 |
| Exposure to beta-cypermethrin impairs the reproductive function of female mice |
7 |
| Safety assessment of ethanolic extract of Olea europaea L. leaves after acute and subacute administration to Wistar rats |
7 |
| Transcriptional profiling of male CD-1 mouse lungs and Harderian glands supports the involvement of calcium signaling in acrylamide-induced tumors |
7 |
| Persistence, dissipation, and risk assessment of a combination formulation of trifloxystrobin and tebuconazole fungicides in/on tomato |
7 |
| Assessment of novel tobacco heating product THP1.0. Part 6: A comparative in vitro study using contemporary screening approaches |
7 |
